Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Artificial Intelligence Comes to the Life Sciences

Posted on September 18th, 2017 by in Pharma R&D

Advances in neural network technology are making it possible to ‘teach’ machines more rapidly—and this machine learning can have big implications for the healthcare and life sciences industry. Continue reading “Artificial Intelligence Comes to the Life Sciences” »

The Challenges of Signal Detection in Spontaneous Reporting

Posted on September 13th, 2017 by in Pharmacovigilance

Pharmacovigilance is essential to pharmaceutical businesses. It facilitates the correct use of a drug, safeguarding the drug as a meaningful treatment option when the benefits it offers outweigh known risks, or measures can be taken to mitigate those risks. Continue reading “The Challenges of Signal Detection in Spontaneous Reporting” »

Taking a Balanced Approach to Monitoring Literature

Posted on September 11th, 2017 by in Pharmacovigilance

In a time when the focus on pharmacovigilance is greater than ever before, literature monitoring presents pharmaceutical companies with significant challenges. Pharmacovigilance groups are looking for ways to efficiently and cost-effectively manage an increasing workload while remaining compliant with regulatory best practices. Continue reading “Taking a Balanced Approach to Monitoring Literature” »

Harnessing the Power of Content in Scientific Research

Posted on September 11th, 2017 by in Pharma R&D

Biological research today can be summarized in one word — data.

Massive quantities of information are generated daily from large and small laboratories, individuals, universities, and commercial organizations. Continue reading “Harnessing the Power of Content in Scientific Research” »

  1. 1
  2. 2